Unknown

Dataset Information

0

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.

ABSTRACT:

SUBMITTER: Al Arashi W 

PROVIDER: S-EPMC6649944 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.

Al Arashi Wala W   Iñiguez Ubiaga Carlota C   Hensor Elizabeth M EM   Gaffney Katie K   Freeston Jane J   Vandevelde Claire C   Barr Andrew A   van der Horst-Bruinsma Irene I   Marzo-Ortega Helena H  

Rheumatology advances in practice 20181018 2

Similar Datasets

Unknown A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics.
| S-EPMC8591959 | biostudies-literature
Unknown Effect of Early Tumor Necrosis Factor Inhibitor Initiation on Chronic Opioid Use in Individuals With Axial Spondyloarthritis.
| S-EPMC12614477 | biostudies-literature
Unknown Construct validity and responsiveness of ASAS Health Index assessed in two longitudinal studies of tumour necrosis factor alpha inhibitor initiation and dose reduction in patients with axial spondyloarthritis.
| S-EPMC11664365 | biostudies-literature
Unknown Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO).
| S-EPMC6518358 | biostudies-literature
Unknown Peripheral Enthesitis Detected by Ultrasonography in Patients With Axial Spondyloarthritis-Anatomical Distribution, Morphology, and Response to Tumor Necrosis Factor-Inhibitor Therapy.
| S-EPMC7381133 | biostudies-literature
Unknown Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study.
| S-EPMC6611048 | biostudies-literature
Unknown Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
| S-EPMC5518107 | biostudies-literature
Unknown Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort.
| S-EPMC11993484 | biostudies-literature
Unknown Measurement of pre-treatment inflammatory cytokine levels is valuable for prediction of treatment efficacy to tumor necrosis factor inhibitor in axial spondyloarthritis patients.
| S-EPMC9542033 | biostudies-literature
Unknown Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.
| S-EPMC4060567 | biostudies-literature